AI in Pharmaceuticals & Drug Discovery

AI accelerates drug discovery, clinical trial optimization, molecule design, and biomedical research for US pharma and biotech companies.

AI Drug Discovery Funding: Why Converge Bio’s $25M Matters

Converge Bio’s $25M Series A highlights where AI drug discovery is heading in 2026—faster decisions, tighter validation, and serious tech investors.